Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
Rei Mizuno, Kenji Kawada, Yoshiharu Sakai
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 24, pp. 6254-6254
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity
Federica Finetti, Cristina Travelli, Jasmine Ercoli, et al.
Biology (2020) Vol. 9, Iss. 12, pp. 434-434
Open Access | Times Cited: 217
Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Constantin Ştefani, Daniela Miricescu, Iulia-Ioana Stănescu-Spînu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10260-10260
Open Access | Times Cited: 217
The Role of Tumor Inflammatory Microenvironment in Lung Cancer
Zhaofeng Tan, Hai-Bin Xue, Yuli Sun, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 134
The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia
Aldona Kasprzak
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1565-1565
Open Access | Times Cited: 109
Arachidonic acid metabolism in health and disease
Yiran Zhang, Yingxiang Liu, Jin Sun, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 81
Extracellular vesicles and particles impact the systemic landscape of cancer
Serena Lucotti, Candia M. Kenific, Haiying Zhang, et al.
The EMBO Journal (2022) Vol. 41, Iss. 18
Open Access | Times Cited: 72
Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4
Ana Santiso, Ákos Heinemann, Julia Kargl
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 388-413
Open Access | Times Cited: 15
Eicosanoids in Cancer: Prostaglandin E2 Receptor 4 in Cancer Therapeutics and Immunotherapy
Mc Millan Ching, Jocelyn Reader, Amy M. Fulton
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 89
Phycocyanin from Arthrospira platensis as Potential Anti-Cancer Drug: Review of In Vitro and In Vivo Studies
S. Braune, A. Krüger-Genge, Sarah Kammerer, et al.
Life (2021) Vol. 11, Iss. 2, pp. 91-91
Open Access | Times Cited: 85
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
Marianna Lucafò, Debora Curci, Martina Franzin, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 82
The Role of Prostaglandins in Different Types of Cancer
Álvaro Jara-Gutiérrez, Victoriano Baladrón
Cells (2021) Vol. 10, Iss. 6, pp. 1487-1487
Open Access | Times Cited: 76
Fatty acids and evolving roles of their proteins in neurological, cardiovascular disorders and cancers
Rahul Mallick, Sanjay Basak, Asim K. Duttaroy
Progress in Lipid Research (2021) Vol. 83, pp. 101116-101116
Open Access | Times Cited: 74
Blocking Dectin-1 prevents colorectal tumorigenesis by suppressing prostaglandin E2 production in myeloid-derived suppressor cells and enhancing IL-22 binding protein expression
Ce Tang, Haiyang Sun, Motohiko Kadoki, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Regulations of Tumor Microenvironment by Prostaglandins
Jeffrey Z. Nie, Man-Tzu Wang, Daotai Nie
Cancers (2023) Vol. 15, Iss. 12, pp. 3090-3090
Open Access | Times Cited: 23
The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition
Fernán Gómez‐Valenzuela, Enrico Escobar, Ricardo Pérez‐Tomás, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 48
Colorectal cancer: Metabolic interactions reshape the tumor microenvironment
Jiawei Chen, Haodong Zhu, Yuhang Yin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188797-188797
Closed Access | Times Cited: 33
Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications
Batol Abbasi, Karim Shamsasenjan, Majid Ahmadi, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 32
Metabolite activation of tumorigenic signaling pathways in the tumor microenvironment
Vivien Low, Zhongchi Li, John Blenis
Science Signaling (2022) Vol. 15, Iss. 759
Closed Access | Times Cited: 29
The Role of Inflammatory Mediators in Colorectal Cancer Hepatic Metastasis
G. Roopa Lavanya, Xiang Xue
Cells (2022) Vol. 11, Iss. 15, pp. 2313-2313
Open Access | Times Cited: 27
Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti–PD-1 resistance
Ashwin Ajith, Kenza Mamouni, Daniel D. Horuzsko, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 21
Open Access | Times Cited: 17
Autophagy and the Insulin-like Growth Factor (IGF) System in Colonic Cells: Implications for Colorectal Neoplasia
Aldona Kasprzak
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3665-3665
Open Access | Times Cited: 16
Salvia mitiorrhiza Bunge aqueous extract attenuates infiltration of tumor-associated macrophages and potentiates anti-PD-L1 immunotherapy in colorectal cancer through modulating Cox2/PGE2 cascade
Mengyao Song, Cheng Qian, Teng Zhang, et al.
Journal of Ethnopharmacology (2023) Vol. 316, pp. 116735-116735
Closed Access | Times Cited: 16
Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy
Wenshuai Li, Xuanxuan Pan, Lirong Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Pathological and pharmacological functions of the metabolites of polyunsaturated fatty acids mediated by cyclooxygenases, lipoxygenases, and cytochrome P450s in cancers
Yi-Wen Meng, Jun‐Yan Liu
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108612-108612
Closed Access | Times Cited: 6
Novel immunotherapies for breast cancer: Focus on 2023 findings
Huanrong Lan, Min Chen, Shi-Ya Yao, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111549-111549
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top